Health Care

AbbVie Inc  (NYSE: ABBV) Q4 2019 Earnings Conference Call February 07, 2020 Corporate Participants: Liz Shea -- Vice President of Investor Relations Richard…

Eli Lilly & Co  (NYSE: LLY) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Kevin Hern -- Vice President of Investor…

Amgen Inc  (NASDAQ: AMGN) Q4 2019 Earnings Conference Call January 30, 2020 Corporate Participants: Arvind Sood -- Vice President of Investor Relations Robert…

-- Neovasc (NASDAQ: NVCN) reported a comprehensive loss of $1.45 per share for Q4 2019 vs. a loss of $5.07…

— Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported a loss of $0.08 per share in the fourth quarter of 2019, in…

Pfizer Inc (NYSE: PFE) Q4 2019 Earnings Conference Call January 28, 2020 Corporate participants: Chuck Triano -- Senior Vice President, Investor Relations…

Johnson & Johnson  (NYSE: JNJ) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations…

Viking Therapeutics Inc  (NASDAQ: VKTX) Q4 2019 Earnings Conference Call February 26, 2020 Corporate Participants: Stephanie C. Diaz -- President and Chief Executive…

Gilead Sciences Inc  (NASDAQ: GILD) Q4 2019 Earnings Conference Call February 04, 2020 Corporate Participants: Douglas Maffei -- Investor Relations Daniel O'Day -- Chairman and…

Teva Pharmaceutical Industries Limited (NYSE: TEVA) Q4 2019 Earnings Conference Call February 12, 2020 Corporate participants: Kevin C. Mannix -- Senior Vice…

The coronavirus pandemic continues to plague the world with over 500,000 cases reported globally and over 82,000 cases in the…

Altimmune Inc. (NASDAQ: ALT) reported its earnings results for fiscal-year 2019. Revenues totaled $5.8 million compared to $10.3 million last…

Ocugen, Inc. (NASDAQ: OCGN) reported a wider loss in fiscal 2019 due to expenses related to the change in fair…

Arguably the most iconic statement made by Warren Buffett to date is – “We simply attempt to be fearful when…

Amarin Corporation plc  (NASDAQ: AMRN) Q4 2019 Earnings Conference Call February 25, 2020 Corporate participants: Elisabeth Schwartz -- Senior Director of Investor…

Biocept, Inc. (NASDAQ: BIOC) reported a narrower loss in the fourth quarter of 2019 driven by higher revenue. The bottom…

-- Onconova Therapeutics (NASDAQ: ONTX) reported FY2019 net loss of $1.49 per share, vs. $4.99 per share last year. --…

Shares of Teva Pharmaceuticals (NYSE: TEVA) fell to a new low this month as markets across the world continued to…

Drugmaker Mylan (NASDAQ: MYL) is all set for a transformation with its planned merger with Upjohn, the generic medicine business…

According to the American Cancer Society, prostate cancer is the second most common form of cancer among men in the US,…

-- Baxter International Inc. (NYSE: BAX) reported Q4 2019 earnings of $0.97 per share, up 37% from last year. --…